PHIO vs BIIB: Which Stock is Better?
Side-by-side comparison of Phio Pharmaceuticals Corp and Biogen Inc in 2026
PHIO
Phio Pharmaceuticals Corp
$1.29
BIIB
Biogen Inc
$177.35
Key Metrics Comparison
| Metric | PHIO | BIIB | Winner |
|---|---|---|---|
| Market Cap | $14.75M | $25.83B | BIIB |
| P/E Ratio | N/A | 20.05 | BIIB |
| EPS (TTM) | $N/A | $8.78 | BIIB |
| Revenue Growth | 0.0% | -0.1% | BIIB |
| Gross Margin | 0.0% | 78.9% | BIIB |
Analyze PHIO
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PHIO or BIIB a better investment?
Comparing PHIO and BIIB: Phio Pharmaceuticals Corp has a market cap of $14.75M while Biogen Inc has $25.83B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PHIO and BIIB?
PHIO (Phio Pharmaceuticals Corp) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PHIO or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: PHIO or BIIB?
PHIO has higher revenue growth at 0.0% vs -0.1% for BIIB.
Which company is more profitable: PHIO or BIIB?
Biogen Inc (BIIB) has higher gross margins at 78.9% compared to 0.0% for PHIO.
Which is the larger company: PHIO or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $25.83B compared to $14.75M for PHIO.
Should I buy PHIO or BIIB in 2026?
Both PHIO and BIIB have investment merit. PHIO trades at $1.29 while BIIB trades at $177.35. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PHIO and BIIB stock?
Key differences: Market Cap ($14.75M vs $25.83B), P/E Ratio (N/A vs 20.0x), Revenue Growth (0.0% vs -0.1%), Gross Margin (0.0% vs 78.9%).